Arthritis Today - April 2004
Leeds – research and treatment united
Treatment of inflammatory arthritis in Leeds is underpinned by a solid research base largely funded by a current investment of almost £3m from arc. Jane Tadman reports.
'World's best' research unit reaches its half-century
Fifty years of epidemiological research is celebrated in Manchester this year. So what exactly does arc's Epidemiology Unit do? Director Alan Silman explains.
Hip op offers more choice
Hip resurfacing offers an alternative to total hip replacement for younger arthritis patients. Jane Tadman reports.
Pushing pain up the agenda: Tender Points and Fibromyalgia
Peter Croft examines the latest thinking about this little-understood condition.
Vasculitis: new hope?
Wegener's granulomatosis, Kawasaki disease, microscopic polyangiitis, polyarteritis nodosa, Churg-Strauss syndrome. Names that hardly trip off the tongue, but this group of diseases, known collectively as vasculitis can cause extreme suffering for the 3,0000 people who are affected in the UK. Jane Tadman reports.
Spotlight on science
Dr Inam Haq and Dr Miep Helfrich explain their work in an ongoing series of questions and answers with arc-funded researchers.
